38 results
8-K
EX-10.1
PHIO
Phio Pharmaceuticals Corp
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous
8-K
EX-10.2
PHIO
Phio Pharmaceuticals Corp
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating
8-K
EX-10.1
PHIO
Phio Pharmaceuticals Corp
20 Apr 23
Phio Pharmaceuticals Announces $2 Million Registered Direct
2:53pm
, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively
8-K
EX-10.1
3qapdfkhvuh6d80dm9f
17 Feb 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
cl54f9ep2193vys
25 Jan 21
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-10.1
cjkvq6u 7la6
2 Apr 20
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-1.1
d7ih0r vzb90qjx
13 Feb 20
Phio Pharmaceuticals Announces Pricing of $8.0 Million
5:25pm
8-K
EX-10.1
02uq3z07atuh
6 Feb 20
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-1.1
nt9jf94d rsgluy
19 Nov 19
Entry into a Material Definitive Agreement
9:29pm
8-K
EX-10.1
5xzs3
9 Aug 19
Entry into a Material Definitive Agreement
5:20pm
8-K
EX-1.1
fepc7wg
5 Oct 18
RXI PHARMACEUTICALS Announces Pricing of $15 Million UPSIZED UNDERWRITTEN Public Offering
5:00pm